ProSolv CardioVascular

Situation

ProSolv Cardiovascular (“ProSolv” or the “Company”) provides an enterprise-level information technology solution for the analysis and management of digital medical images in the area of cardiology.

Located in Indianapolis, Indiana, the Company has an installed base of over 275 sites in the U.S., Canada, the United Kingdom, Australia, New Zealand, and Japan.

Solution

Amherst professionals were engaged to assist the founder and CEO in assessing and responding to the acquisition inquiries of a multi-national strategic buyer.

Amherst team was actively involved in developing a tactical plan for engaging the prospective buyer, as well as leading the negotiations regarding purchase price and principal deal terms.

Results

ProSolv was ultimately sold to Fujifilm Medical Systems USA. The Company realized a valuation that was in excess of the original valuation proposed by the buyer.

In addition, the founder was successful in negotiating retention of the rights to the software source code for all applications other than in the field of medicine.